Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 34Peritoneal Neoplasms 17Colorectal Neoplasms 14Ovarian Neoplasms 7Appendiceal Neoplasms 7Pancreatic Neoplasms 4Neoplasm Metastasis 4Uterine Neoplasms 3Fallopian Tube Neoplasms 3Uterine Cervical Neoplasms 2Pseudomyxoma Peritonei 2Peritoneal Diseases 2Neoplasms 2Mesothelioma, Malignant 2Mesothelioma 2Gastrointestinal Neoplasms 2Gastric Adenocarcinoma 2Colonic Neoplasms 2Carcinoma 2Stomach Diseases 1Stage â…¢ Gastric Cancer 1Stage IV Gastric Cancer With Metastasis 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Pleural Effusion 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pelvic Neoplasms 1Locally Advanced Gastric Cancer 1

Interventions

camrelizumab 4Oxaliplatin 3apatinib 2S 1 (combination) 2Capecitabine 2XELOX 1Taxes 1Surgical Procedures, Operative 1Nivolumab 1Laparoscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Gastrectomy 1Conversion to Open Surgery 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Gastric Cancer × Hyperthermic Intraperitoneal Chemotherapy × Gastrointestinal × Clear all
NCT07621484 2026-06-02

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

Shanghai Changzheng Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡